THE AMERICA ONE NEWS
Jun 24, 2025 |
0
| Remer,MNSponsor: QWIKET
Sponsor: QWIKET
Sponsor: QWIKET: Sports Knowledge
Sponsor: QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor: QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
topic
Forbes
17 Jul 2023
The Food and Drug Administration approved the monoclonal antibody treatment Beyfortus to prevent respiratory syncytial virus—the leading cause of hospitalizations in U.S. infants less than a year old.
RSV often results in emergency room visits for infants under a year old who contract the virus. ... [+]
The drug—made by AstraZeneca—will be administered as a single injection to infants prior to RSV season in the latter months of the year.
Around 2% of children less than a year old are hospitalized by RSV every year, according to the American Academy of Pediatrics.
This is a developing story. Check back for updates.